—
European Medicines Agency (continuation of debate)
Despite a number of warnings, we have seen the pandemic unprepared. This was best illustrated by the shortage of medicines and medical equipment due to the surge in demand that we were unable to respond to in a timely manner with a rapid increase in production capacity and the complexity of the global supply chain for medical devices. That is why, building on this experience, today we are voting to strengthen the European Medicines Agency to provide a long-term framework to respond to future health crises: a framework that establishes a system for monitoring and mitigating the risk of shortages of critical medicinal products and medical devices and ensures the timely development of high-quality, safe and effective emergency medicinal products. The pandemic has shown that we need a strong European Health Union to cope with the consequences of health threats in the future. Now is the time to do everything in our power to ensure that our citizens never again find themselves in a situation where essential medicines and medical equipment are lacking. Strengthening the European Medicines Agency is the first step towards this.